Immune Netw.  2009 Aug;9(4):133-137. 10.4110/in.2009.9.4.133.

Further Characterization of Activin A-induced IgA Response in Murine B Lymphocytes

Affiliations
  • 1Department of Molecular Bioscience, School of Bioscience and Biotechnology, Kangwon National University, Chuncheon 200-701, Korea. phkim@kangwon.ac.kr
  • 2Medical & Bio-material Research Center, Kangwon National University, Chuncheon 200-701, Korea.

Abstract

We have recently shown that activin A, a member of TGF-beta superfamily, stimulates mouse B cells to express IgA isotype but other isotypes. In the present study, we further characterized effects of activin A on B cell growth and IgA expression. We found that activin A did not have effect on LPS-stimulated cell viability. In parallel, CFSE staining analysis revealed that activin A did not alter cell division. An increase of IgA secretion by activin A was completely abrogated by anti-activin A Ab but not by anti-TGFbeta1 Ab. In the same conditions, no other isotypes are significantly affected by each antibody treatment. Finally, activin A, as similar to TGF-beta1, increased IgA secretion by mesenteric lymph node cells. These results suggest that activin A can specifically stimulate IgA response, independent of TGF-beta in the gut.

Keyword

activin A; TGF-beta; IgA; mesenteric lymph node; CFSE

MeSH Terms

Activins
Animals
B-Lymphocytes
Cell Division
Cell Survival
Fluoresceins
Immunoglobulin A
Lymph Nodes
Mice
Succinimides
Transforming Growth Factor beta
Transforming Growth Factor beta1
Activins
Fluoresceins
Immunoglobulin A
Succinimides
Transforming Growth Factor beta
Transforming Growth Factor beta1

Figure

  • Figure 1 Effect of activin A and TGF-β1 on the growth kinetics of splenic B cells. Normal spleen B cells (1×106) stimulated with LPS were cultured in the presence of TGF-β1 (0.2 ng/ml) and activin A (10 ng/ml). Numbers of viable cells were enumerated by trypan blue exclusion. Data are means±SEM (bars) of triplicate culture wells.

  • Figure 2 Effect of activin A on B cell proliferation. CFSE-labeled splenic B cells (1×106) were cultured as in Fig. 1. After 48 h, 72 h, and 96 h incubation, B cell proliferation was assessed by analyzing the dilution of CFSE in the same number of viable cells.

  • Figure 3 Effect of anti-activin A Ab on IgA secretion by B lymphoma cells. B lymphoma cells were stimulated with LPS (12.5µg/ml) and activin A (10 ng/ml). Titrated anti-activin A Ab and anti-TGF-β Ab were pre-incubated for 1 h at room temperature before addition to culture. Supernatants were harvested after 3 days of culture. IgA secretion was determined by ELISA. Data are means of triplicate cultures±SEM.

  • Figure 4 Effect of anti-activin A Ab on Ig secretion by normal spleen B cells. Mouse spleen B cells were stimulated with LPS (12.5 g/ml) and activin A (10 ng/ml). As in Fig. 3, anti-activin A Ab (0.5µg/ml) and anti-TGF-β Ab (5µg/ml) were added to cultures. Supernatants were harvested after 7 days of culture. Secretion of Ig isotypes was determined by ELISA. Data are means of triplicate cultures±SEM.

  • Figure 5 Activin A increases IgA secretion by mesenteric lymph node cells. Mesenteric lymph node (1×106) cells were treated 10 ng/ml of activin A, and 0.2 ng/ml of TGF-β1. Supernatants were harvested after 7 days of culture. IgA, IgG1, and IgG2b secretion was determined by ELISA. Data are means of triplicate cultures±SEM.


Reference

1. Mestecky J. The common mucosal immune system and current strategies for induction of immune responses in external secretions. J Clin Immunol. 1987. 7:265–276.
Article
2. van der Heijden PJ, Stok W, Bianchi AT. Contribution of immunoglobulin-secreting cells in the murine small intestine to the total 'background' immunoglobulin production. Immunology. 1987. 62:551–555.
3. Fagarasan S, Honjo T. Intestinal IgA synthesis: regulation of front-line body defences. Nat Rev Immunol. 2003. 3:63–72.
Article
4. Kim PH, Kagnoff MF. Transforming growth factor-beta 1 is a costimulator for IgA production. J Immunol. 1990. 144:3411–3416.
5. Sonoda E, Matsumoto R, Hitoshi Y, Ishii T, Sugimoto M, Araki S, Tominaga A, Yamaguchi N, Takatsu K. Transforming growth factor beta induces IgA production and acts additively with interleukin 5 for IgA production. J Exp Med. 1989. 170:1415–1420.
Article
6. Coffman RL, Lebman DA, Shrader B. Transforming growth factor beta specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes. J Exp Med. 1989. 170:1039–1044.
Article
7. van Vlasselaer P, Punnonen J, de Vries JE. Transforming growth factor-beta directs IgA switching in human B cells. J Immunol. 1992. 148:2062–2067.
8. Spieker-Polet H, Yam PC, Arbieva Z, Zhai SK, Knight KL. In vitro induction of the expression of multiple IgA isotype genes in rabbit B cells by TGF-beta and IL-2. J Immunol. 1999. 162:5380–5388.
9. McIntyre TM, Klinman DR, Rothman P, Lugo M, Dasch JR, Mond JJ, Snapper CM. Transforming growth factor beta 1 selectivity stimulates immunoglobulin G2b secretion by lipopolysaccharide-activated murine B cells. J Exp Med. 1993. 177:1031–1037.
Article
10. Kehrl JH, Taylor A, Kim SJ, Fauci AS. Transforming growth factor-beta is a potent negative regulator of human lymphocytes. Ann N Y Acad Sci. 1991. 628:345–353.
Article
11. Smeland EB, Blomhoff HK, Holte H, Ruud E, Beiske K, Funderud S, Godal T, Ohlsson R. Transforming growth factor type beta (TGF beta) inhibits G1 to S transition, but not activation of human B lymphocytes. Exp Cell Res. 1987. 171:213–222.
Article
12. Cross D, Cambier JC. Transforming growth factor beta 1 has differential effects on B cell proliferation and activation antigen expression. J Immunol. 1990. 144:432–439.
13. Luisi S, Florio P, Reis FM, Petraglia F. Expression and secretion of activin A: possible physiological and clinical implications. Eur J Endocrinol. 2001. 145:225–236.
Article
14. Ogawa K, Funaba M, Chen Y, Tsujimoto M. Activin A functions as a Th2 cytokine in the promotion of the alternative activation of macrophages. J Immunol. 2006. 177:6787–6794.
Article
15. Lee HJ, Seo GY, Kim HA, Kim PH. Activin A stimulates IgA expression in mouse B cells. Biochem Biophys Res Commun. 2008. 366:574–578.
Article
16. Nakamura M, Kondo S, Sugai M, Nazarea M, Imamura S, Honjo T. High frequency class switching of an IgM+ B lymphoma clone CH12F3 to IgA+ cells. Int Immunol. 1996. 8:193–201.
Article
17. Park SR, Lee JH, Kim PH. Smad3 and Smad4 mediate transforming growth factor-beta1-induced IgA expression in murine B lymphocytes. Eur J Immunol. 2001. 31:1706–1715.
Article
18. Kim PH, Kagnoff MF. Transforming growth factor beta 1 increases IgA isotype switching at the clonal level. J Immunol. 1990. 145:3773–3778.
19. Craig SW, Cebra JJ. Peyer's patches: an enriched source of precursors for IgA-producing immunocytes in the rabbit. J Exp Med. 1971. 134:188–200.
Article
20. Santiago AF, Fernandes RM, Santos BP, Assis FA, Oliveira RP, Carvalho CR, Faria AM. Role of mesenteric lymph nodes and aging in secretory IgA production in mice. Cellular immunology. 2008. 253:5–10.
Article
21. Kawanishi H, Saltzman L, Strober W. Mechanisms regulating IgA class-specific immunoglobulin production in murine gut-associated lymphoid tissues. II. Terminal differentiation of postswitch sIgA-bearing Peyer's patch B cells. J Exp Med. 1983. 158:649–669.
Article
Full Text Links
  • IN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr